AI is everywhere in biotech, but where does it genuinely create impact?

In this episode of the ThinkData Podcast, I sat down with Josh Haimson, Co-Founder and CEO of Inductive Bio, to explore how AI-driven virtual chemistry labs are transforming drug discovery.

We cover:

1. Where AI truly outperforms traditional approaches in drug development
2. Why computational models are finally earning real trust from scientists
3. What Inductive Bio’s Series A unlocked, and how they’re balancing speed vs depth
4. The role of industry partnerships and early adopters in shaping the platform
5. Where are the biggest AI opportunities in drug discovery over the next 3–5 years

A grounded, technical, and refreshingly honest conversation about the future of AI-powered therapeutics.